Rocket Pharmaceuticals Inc (NAS:RCKT)
$ 17.19 0.37 (2.2%) Market Cap: 1.56 Bil Enterprise Value: 1.28 Bil PE Ratio: 0 PB Ratio: 4.06 GF Score: 36/100

Rocket Pharmaceuticals Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript

Apr 25, 2023 / 01:00PM GMT
Release Date Price: $17.77 (-2.58%)
Geulah Livshits
Chardan Capital Markets, LLC. - Analyst

Good morning, and welcome to the second day of Chardan Genetic Medicines and Cell Therapy Manufacturing Summit. I'm Geulah Livshits, and our compliance team has asked me to read this statement for today's session.

By participating in this event, our speakers attest that they have made certain aware of any potential conflicts, and they will not discuss any material non-public or confidential information that they're aware of that may breach their legal, regulatory, or fiduciary responsibility to any party.

So with that done, it's now my pleasure to introduce Dr. Kinnari Patel, President and Chief Operating Officer of Rocket Pharma. The format for this session is roughly a 25-minute fireside chat. If you have any questions in the session, feel free to take them into the question box.

Questions & Answers

Geulah Livshits
Chardan Capital Markets, LLC. - Analyst

So Kinnari, thank you for joining us. To start, could you please discuss Rocket's manufacturing capabilities and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot